Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
525.60
Change Change %
-5.95 -1.12%

Updated:20 Nov, 2018, 15:09 PM IST

BSE
525.50
Change Change %
-5.05 -0.95%

Updated:20 Nov, 2018, 15:15 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Citi
N/A
18-11-2015 Buy 758.00 1020.00
N/A
Closed Custom
18-11-2016

Citi maintains buy on Sun Pharma

Risk-reward on Sun Pharma appears favourable for investors. See meaningful gains from Ranbaxy. Synergies from Ranbaxy would drive medium term growth. Target of Rs 1,020 is based on 27 times FY18 estimated earnings per share.

Top